Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Jan 25 | CRIS Curis | Non Qualified Stock Option Common Stock | Grant | Acquire A | No | No | 3.13 | 1,600 | 5.01 k | 1,600 |
20 Jun 24 | NXTC NextCure | Stock Option Common Stock | Grant | Acquire A | No | No | 1.5 | 18,700 | 28.05 k | 18,700 |
21 May 24 | CRIS Curis | Non Qualified Stock Option Common Stock | Grant | Acquire A | No | No | 11.62 | 4,250 | 49.39 k | 4,250 |
5 Mar 24 | STRO Sutro Biopharma | RSU Common Stock | Grant | Acquire A | No | No | 0 | 45,000 | 0.00 | 45,000 |
5 Mar 24 | STRO Sutro Biopharma | Stock Option (Right to Buy Common Stock) Common Stock | Grant | Acquire A | No | No | 4.54 | 60,000 | 272.40 k | 60,000 |
29 Feb 24 | STRO Sutro Biopharma | Common Stock | Payment of exercise | Dispose F | No | No | 4.91 | 13,126 | 64.45 k | 24,374 |
29 Feb 24 | STRO Sutro Biopharma | Common Stock | Option exercise | Acquire M | No | No | 0 | 37,500 | 0.00 | 37,500 |
29 Feb 24 | STRO Sutro Biopharma | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 37,500 | 0.00 | 112,500 |